These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9378844)

  • 1. Pharmacokinetics and safety of the novel amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist YM90K in healthy men.
    Umemura K; Kondo K; Ikeda Y; Teraya Y; Yoshida H; Homma M; Uematsu T; Nakashima M
    J Clin Pharmacol; 1997 Aug; 37(8):719-27. PubMed ID: 9378844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of metabolites of [14C]zonampanel, an a-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist, following intravenous infusion in healthy volunteers.
    Minematsu T; Sohda KY; Hashimoto T; Imai H; Usui T; Kamimura H
    Xenobiotica; 2005 Apr; 35(4):359-71. PubMed ID: 16019957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.
    Yao H; Ibayashi S; Nakane H; Cai H; Uchimura H; Fujishima M
    Brain Res; 1997 Apr; 753(1):80-5. PubMed ID: 9125434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia.
    Umemura K; Shimakura A; Nakashima M
    Brain Res; 1997 Oct; 773(1-2):61-5. PubMed ID: 9409705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats.
    Kawasaki-Yatsugi S; Yatsugi S; Koshiya K; Shimizu-Sasamata M
    Jpn J Pharmacol; 1997 Jul; 74(3):253-60. PubMed ID: 9268085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats.
    Yatsugi S; Takahashi M; Kawasaki-Yatsugi S; Koshiya K; Sakamoto S; Uematsu D; Shimizu-Sasamata M
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):959-66. PubMed ID: 8784240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AMPA-receptor antagonist YM90K reduces AMPA receptor-mediated excitotoxicity in rat hippocampal cultures.
    Ohno K; Okada M; Tsutsumi R; Sakamoto S; Yamaguchi T
    Jpn J Pharmacol; 1998 Jan; 76(1):105-8. PubMed ID: 9517411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Shimizu-Sasamata M; Yatsugi S; Yamaguchi T
    J Pharm Pharmacol; 1998 Aug; 50(8):891-8. PubMed ID: 9751454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Ichiki C; Yatsugi S; Shimizu-Sasamata M; Yamaguchi T
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):586-91. PubMed ID: 9840429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YM90K, an AMPA antagonist, has no neurotoxic effects on cerebrocortical neurons in rats.
    Izumisawa N; Kawakami A; Ohata T; Hanada T; Okeda R
    Exp Neurol; 1995 Aug; 134(2):199-204. PubMed ID: 7556539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of YM90K, a selective and potent antagonist of AMPA receptors, in rat cortical mRNA-injected Xenopus oocytes.
    Okada M; Kohara A; Yamaguchi T
    Eur J Pharmacol; 1996 Aug; 309(3):299-306. PubMed ID: 8874154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent AMPA/kainate receptor antagonist, YM90K, attenuates the loss of N-acetylaspartate in the hippocampal CA1 area after transient unilateral forebrain ischemia in gerbils.
    Nakano M; Ueda H; Li JY; Matsumoto M; Yanagihara T
    Life Sci; 2001 Sep; 69(17):1983-90. PubMed ID: 11589513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist.
    Kohara A; Okada M; Tsutsumi R; Ohno K; Takahashi M; Shimizu-Sasamata M; Shishikura J; Inami H; Sakamoto S; Yamaguchi T
    J Pharm Pharmacol; 1998 Jul; 50(7):795-801. PubMed ID: 9720630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters.
    Hashimoto T; Narikawa S; Huang XL; Minematsu T; Usui T; Kamimura H; Endou H
    Drug Metab Dispos; 2004 Oct; 32(10):1096-102. PubMed ID: 15377641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat.
    Kodama M; Yamada N; Sato K; Kitamura Y; Koyama F; Sato T; Morimoto K; Kuroda S
    Eur J Pharmacol; 1999 Jun; 374(1):11-9. PubMed ID: 10422635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid.
    Dalgaard L; Hjortkjaer RK; Regnier B; Nordholm L
    Drug Metab Dispos; 1994; 22(2):289-93. PubMed ID: 7912178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of organic anion transporters in the pharmacokinetics of zonampanel, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist, in rats.
    Minematsu T; Hashimoto T; Aoki T; Usui T; Kamimura H
    Drug Metab Dispos; 2008 Aug; 36(8):1496-504. PubMed ID: 18443035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroprotective effect of the novel AMPA receptor antagonist PD152247 (PNQX) in temporary focal ischemia in the rat.
    Schielke GP; Kupina NC; Boxer PA; Bigge CF; Welty DF; Iadecola C
    Stroke; 1999 Jul; 30(7):1472-7. PubMed ID: 10390325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.